Show Stocks and Investing Publications • Fri, May 5, 2023
Andrew Fein Reiterated (STOK) at Strong Buy and Held Target at $35 on, May 5th, 2023
ein-reiterated-stok-at-strong-buy-and-held-target-at-35-on-may-5th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIAndrew Fein of HC Wainwright & Co., Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $35 on, May 5th, 2023.
Andrew has made no other calls on STOK in the last 4 months.
There are 4 other peers that have a rating on STOK. Out of the 4 peers that are also analyzing STOK, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Greg Harrison of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $12 on, Monday, May 1st, 2023
These are the ratings of the 3 analyists that currently disagree with Andrew
- Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $24 on, Wednesday, April 26th, 2023
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $20 on, Tuesday, March 7th, 2023
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
Like: 👍